Jefferies downgraded Brightpoint (NASDAQ: CELL) to a Hold rating from its previous rating of Buy. The firm keeps their price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE